Proactive AI-based ICU patient monitoring cleared for market

The FDA has OK’d AI software that can predict worsening condition in ICU patients up to eight hours before the falloff produces symptoms.

Clew Medical announced the market readiness of its ClewICU this week. The company says the technology works by recognizing hemodynamic instability, a disruption in the flow of blood through the body. It receives the relevant data from electronic medical records as well as from bedside monitoring devices.

The system analyzes these data streams in near real-time to “present calculated insights and notifications for dedicated AI models and [provide] a picture of overall unit status,” Clew Medical states.

The toolkit also points out ICU patients who are not in danger of increasing hemodynamic instability. Clew Medical notes this capability can facilitate smarter resource consumption in the ICU.